期刊文献+

彩色多普勒超声对门静脉癌栓肝动脉血流动力学变化的研究 被引量:3

A study of the hepatic artery blood flow in portal stem vein tumor thrombus with color Doppler ultrasound
原文传递
导出
摘要 目的探讨肝细胞癌合并门静脉主干癌栓时的肝动脉血流动力学变化。方法将60例肝细胞癌合并门静脉主干癌栓患者根据癌栓对门静脉主干的阻塞程度分为部分性阻塞组和完全性阻塞组,每组30例,应用彩色多普勒超声测量肝固有动脉内径(PHA-D)、收缩期最大血流速度(Vmax)以及阻力指数(RI),并与80例肝细胞癌无门静脉癌栓患者(肝癌组)和20例健康体检者(对照组)作对比。结果对照组、肝癌组、部分性阻塞组、完全性阻塞组PHA-D分别为(O.33±0.05)、(O.44±0.04)、(0.45±0.04)、(0.61±0.07)cm,Vmax分别为(31.32±9.31)、(66.76±20.34)、(68.16±21.96)、(132.65±38.84)cm/s,R1分别为0.75±0.08、0.68±0.13、0.65±0.11、0.55±0.10。肝癌组、部分性阻塞组、完全性阻塞组PHA.D、V—RI与对照组比较差异均有统计学意义(P〈0.01或〈0.05);完全性阻塞组PHA-D、Vmax、RI与肝癌组和部分性阻塞组比较差异均有统计学意义(P〈0.01)。结论肝细胞癌合并门静脉主干癌栓时,肝动脉血流量明显代偿性增加,RI明显减低,但肝动脉血流动力学的改变主要取决于癌栓对门静脉主干的阻塞程度,而并非取决于门静脉癌栓的有无。 Objective To investigate the hemodynamic changes of the proper hepatic artery (PHA) in hepatocellular carcinoma (HCC) and portal stem vein tumor thrombus. Methods Sixty HCC and portal stem vein tumor thrombus patients were divided into partial occlusion group and completely occlusion group with 30 patients each. Eighty HCC patients without portal stem vein tumor thrombus were in HCC group and 20 health cases were in control group. Color Doppler ultrasound was used to measure the diameter of PHA (PHA-D), systolic maximal velocity (Vmax) and resistant index (RI) of PHA. Results PHA-D in control group,HCC group,partial occlusion group and completely occlusion group was (0.33 ± 0.05), (0.44 ± 0.04), (0.45 ± 0.04), (0.61 ± 0.07) cm,Vmax was (31.32 ± 9.31), (66.76 ± 20.34), (68.16 ± 21.96), ( 132.65 ± 38.84) cm/s, RI was 0.75 ± 0.08,0.68 ±0. 13,0.65 ± 0.11,0.55 ± 0.10, respectively. The levels of PHA-D, Vm and RI in HCC group, partial occlusion group and completely occlusion group had significant difference compared with those in control group (P 〈 0.01 or 〈 0.05). The levels of PHA-D, Vmax and RI in completely occlusion group had significant difference compared with those in HCC group, partial occlusion group(P 〈 0.01 ). Conclusions The blood flux obviously ascends compensatorily in HCC with portal stem vein tumor thrombus, RI obviously descends. But it is the occlusive nature of the tumor thrombus that is crucial to the hemodynamic change of the proper hepatic artery.
出处 《中国医师进修杂志》 2012年第23期33-35,共3页 Chinese Journal of Postgraduates of Medicine
关键词 肝细胞 超声检查 多普勒 彩色 门静脉 肝动脉 Carcinoma, hepatocellular Ultrasonography, Doppler, color Portal vein Hepatic artery
  • 相关文献

参考文献2

共引文献18

同被引文献33

  • 1陆再英,钟南山.内科学[M].7版.北京:人民卫生出版社,2008:382.
  • 2Luo J, Guo RP, Lai EC, et al. Transartefial chemoembolization for unresectable hepatoeellular carcinoma with portal vein tumor thrombosis : a prospective comparative study [ J ]. Ann SurgOneol, 2011, 18(2) : 413-420.
  • 3Chung GE, Lee JH, Kim HY, et al. tion can be safely performed in patients withhepatoeellular carcino- ma invading the main portal vein and may improve the overall sur- vival rJT. Radioloav. 2011. 258(2) ,627-634.
  • 4Park JW, Koh YH, Kim HB, et al. Phase I1 study of concurrent transarterial chemoembolization and sorafenib for patients with unr- esectable hepatocellular carcinoma[J]. J Hepatol, 2012, 56(6) : 1336-1342.
  • 5Cabrera R, Pannu DS, Caridi J, et al. The combination ofsor- afenib with for hepatocellularcarci- noma [J]. Aliment Pharmacol Ther, 2011, 34(2) : 205-213.
  • 6Dufour JF, Johnson P. Liver cancer: from molecular pathogenesis- to new therapies: summary of the EASL single topicconference [J]. J Hepatol, 2010, 52(2) : 296-304.
  • 7Forner A, Reig ME, de Lope CR, et al. Current strategy forstag- ing and treatment: the BCLC update and future prospects[ J]. Se- min Liver Dis, 2010, 30(1) : 61-74.
  • 8Cheng AL, Kang YK, Chen Z, et al. Efficacy and safety ofsor- afenib in patients in the Asia-Pacific region with advanced hepa- tocellular carcinoma: a phase II1 randomised, doubleblind, pla- cebo-controlled trial [ J]. Lancet Oncol, 2009, 10 ( 1 ) : 25-34.
  • 9Kobayashi S, Nagano H, Marubashi S, et al. Hepatectomy based on the rumor hemodynamics for hepatocellular carcinoma: a comparison among the hybrid and pure laparoscopic procedures and open surgery[J]. Surg Endosc, 2013, 27 (2): 610-617.
  • 10Albers I, Hartmann H, Bircher J, et al. Superiority of the Child-Pugh classification to quantitative liver function tests for assessing prognosis of liver cirrhosis[J]. Scand J Gastroenterol, 1989, 24(3): 269-276.

引证文献3

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部